David W Meline Moderna, Inc. (MRNA) insider trading activity

David W Meline is Chief Financial Officer of Moderna, Inc.. Currently has a direct ownership of 2,857 shares of MRNA, which is worth approximately $227,160. The most recent transaction as insider was on Aug 10, 2022, when has been sold 164 shares (Common Stock) at a price of $173.66 per share, resulting in proceeds of $28,480. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.86K

0% 3M change

0% 12M change

Total Value Held $227,160

David W Meline Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 10 2022	SELL Open market or private sale	$28,480 $173.66 p/Share	164 Reduced 5.43%	2,857 Common Stock
Aug 09 2022	BUY Exercise of conversion of derivative security	-	348 Added 10.33%	3,021 Common Stock
May 10 2022	SELL Open market or private sale	$20,859 $133.71 p/Share	156 Reduced 5.7%	2,583 Common Stock
May 09 2022	BUY Exercise of conversion of derivative security	$46,771 $134.4 p/Share	348 Added 11.27%	2,739 Common Stock
Feb 10 2022	SELL Open market or private sale	$98,353 $158.89 p/Share	619 Reduced 20.56%	2,391 Common Stock
Feb 09 2022	BUY Exercise of conversion of derivative security	-	1,392 Added 31.62%	3,010 Common Stock

Also insider at

AMGN

AMGEN INC Healthcare

EVP & CFO

PACB

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Healthcare

Director

HPQ

HP INC Technology

DWM

David W Meline

Chief Financial Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account